Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1792

Actual shortage: 56 (3%)
Anticipated shortage: 1 (0%)
Avoided shortage: 13 (1%)
Resolved: 1722 (96%)

Discontinuation Reports

71

To be discontinued: 1 (1%)
Discontinued: 68 (96%)
Reversed: 2 (3%)

Late reports

439 (24%)

Overdue reports

6 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-13 2018-04-19 45809
SANDOZ OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-13 2018-04-19 45812
SANDOZ OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-19 2020-08-24 115319
SANDOZ OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-19 2020-08-24 115322
SANDOZ OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-19 2020-08-24 115325
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-19 2020-08-24 115328
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-11-09 2020-12-07 128163
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-12-14 2021-01-12 130134
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-01-12 2022-02-08 152596
SANDOZ OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-01-26 2022-02-08 153594
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-06-09 2022-06-18 162366
SANDOZ OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-07-24 2023-09-20 199817
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-08-21 2023-10-17 202544
SANDOZ OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-09-19 2023-10-17 204741
SANDOZ OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-04 2024-01-03 212451
SANDOZ OLMESARTAN 40MG TABLET Resolved 2017-07-24 2017-09-06 16750
SANDOZ OLMESARTAN 40MG TABLET Resolved 2017-09-07 2017-11-13 21291
SANDOZ OLMESARTAN 20MG TABLET Resolved 2017-11-14 2018-05-23 29204
SANDOZ OLMESARTAN 20MG TABLET Resolved 2018-02-05 2018-04-19 38739
SANDOZ OLMESARTAN 40MG TABLET Resolved 2018-02-12 2018-05-03 39578

Showing 1181 to 1200 of 1792

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Discontinued 2020-06-22 2020-06-22 118553
POLYTOPIC 500UNIT 10000UNIT OINTMENT Discontinued 2020-04-01 2020-04-01 110309

Showing 1 to 20 of 71